Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.


Read our formal press statements on significant topics and events.

32 Results

10 Feb 2016

Tamiflu 2015-16 Flu Season Supply

Based upon our current forecasts, we anticipate having sufficient supply of both Tamiflu® (oseltamivir phosphate) formulations (oral suspension and capsules) for the 2015-16 flu season…

17 Jul 2015

Genentech Statement On Updated ATS Guidelines

Esbriet Is Recommended In The American Thoracic Society’s (ATS) Idiopathic Pulmonary Fibrosis (IPF) Treatment Guidelines New clinical practice guidelines recommend Esbriet® (pirfenidone) for…